U.S. SUCRALFATE MARKET ANALYSIS

U.S. Sucralfate Market by Formulation (Tablet and Liquid Suspension), by Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and Others Indications), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York, California, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published In : Aug 2019
Code : CMI2975
Pages :129
Formats :
Excel and PDF
Industry : Pharmaceutical

U.S. Sucralfate MarketSize and Trends

U.S. Sucralfate Market – Market Insights

The U.S. sucralfate market size was valued at US$ 296.2 million in 2017, and is expected to exhibit a CAGR of 3.1% over the forecast period (2018–2026).

Increasing prevalence of gastrointestinal disorders and H. pylori-associated infections is expected to propel the market growth

Rising incidence of gastric ulcers caused due to use of nonsteroidal anti-Inflammatory drugs (NSAID) and H. pylori infection is expected to drive the U.S. sucralfate market. According to the study by Deccan College of Medical Sciences, 2016, an estimated 95% of duodenal and 70% of gastric ulcers are caused due to Helicobacter pylori. Furthermore, the same study also stated that around 14-25% of gastric and duodenal ulcers are associated with NSAID use.

Rising prevalence of peptic ulcers is expected to bolster the market growth. According to the data published by ScienceDirect Journal in 2016, duodenal ulcers are more common type of peptic ulcers and its prevalence was around 6% to 12% in the U.S.